Product Details
Synonyms
CD56, MSK39, NCAM1, N-CAM-1
Source
Human NCAM-1, Fc Tag (NC1-H5253) is expressed from human 293 cells (HEK293). It contains AA Leu 20 - Gly 718 (Accession # P13591-2).
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a human IgG1 Fc tag at the C-terminus.
The protein has a calculated MW of 104.0 kDa. The protein migrates as 130-150 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin
Less than 0.2 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
>95% as determined by SEC-MALS.
Formulation
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
Reconstitution
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
Storage
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- -20°C to -70°C for 12 months in lyophilized state;
- -70°C for 3 months under sterile conditions after reconstitution.
ACRO Quality Management System
Kunden haben auch angesehen
Data Display
SDS-PAGE

Human NCAM-1, Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
SEC-MALS

The purity of Human NCAM-1, Fc Tag (Cat. No. NC1-H5253) is more than 95% and the molecular weight of this protein is around 295-310 kDa verified by SEC-MALS.
Report
Bioactivity-ELISA

Immobilized Human NCAM-1, Fc Tag (Cat. No. NC1-H5253) at 1 μg/mL (100 μL/well) can bind Anti-NCAM-1 Antibody, Human IgG1 with a linear range of 0.3-10 ng/mL (QC tested).
Protocol
User Reviews Publish Comment

Background Introduction
Frontier Progress
- English Name:
Neural cell adhesion molecule 1
- Category:
- Listed Drugs Count:
0 Details
- Clinical Drugs Count:
5 Details
- Highest R&D Stage:
Phase 2 Clinical



















